Log In
Print
BCIQ
Print
Print this Print this
 

MDT-637

  Manage Alerts
Collapse Summary General Information
Company MicroDose Therapeutx Inc.
DescriptionInhalable small molecule antiviral fusion inhibitor delivered using dry powder nebulizer technology
Molecular Target
Mechanism of Action 
Latest Stage of DevelopmentPhase II
IndicationRespiratory syncytial virus (RSV)
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today